COA Available
Healing & Recovery In Stock Research Use Only
TB-500
10mg · Lyophilized Powder · Purity ≥99%
TB-500 is the research designation for a Thymosin Beta-4 acetate fragment, studied in preclinical models examining tissue repair, cellular movement, and blood vessel formation processes.
$69.99 CAD
Purchase Options
Subscriptions can be managed from your customer account. Prices in CAD.
Research Overview
TB-500 refers to a synthetic fragment of Thymosin Beta-4, a naturally occurring protein with roles in actin regulation and cellular signalling. Research interest in TB-500 spans tissue integrity, cellular motility (the directed movement of cells through tissue environments), and angiogenesis (the formation of new blood vessels from existing vasculature) — processes commonly studied in preclinical recovery and wound biology research. This vial contains 10mg of TB-500 supplied as a lyophilized powder at ≥99% purity, with batch-level testing documentation available in the COA tab. This product is supplied exclusively for laboratory and research use — not for human or animal consumption.
TB-500 is investigated within the broader field of cytoskeletal and extracellular matrix research. Its parent molecule, Thymosin Beta-4, has been the subject of substantial scientific literature examining actin-binding interactions, wound healing models, and vascular biology in animal research contexts. TB-500 is frequently referenced as a research tool in models studying cellular regeneration signalling. All research applications referenced in scientific literature involve preclinical in-vitro or animal model contexts and do not constitute evidence of efficacy or safety in human or clinical settings.
Specifications
| Compound | TB-500 |
| Format | Lyophilized Powder |
| Size | 10mg |
| Purity (HPLC) | ≥99% |
| Item # | BME-TB5001-A |
| Storage | −20°C, dry, dark |
| Price (CAD) | $69.99 |
COA / Testing
Batch documentation and third-party testing information are available for batch BME-TB5001-A. COA previews appear only when documentation exists for the active batch.
Storage & Handling
Store lyophilized TB-500 powder at −20°C in a sealed, light-protected container prior to any research use. Peptide-based compounds in this structural class are sensitive to moisture and prolonged exposure to ambient temperatures. Minimize the number of freeze-thaw cycles to preserve compound integrity. Once prepared for a research application, handle according to your laboratory's standard protocols for synthetic peptide fragments.
Shipping & Returns
Orders are processed on business days. Packaging is selected to maintain compound integrity in transit. Shipping timelines and return conditions are outlined in full in the Shipping & Returns policy — review before checkout if you have specific requirements. For orders with time-sensitive research schedules, contact support before placing your order.
Research Use Disclaimer
This product is supplied strictly for in-vitro and laboratory research use. It is not a drug, food supplement, or cosmetic and is not approved for human or veterinary clinical applications, diagnostics, or therapeutic use. Researchers are responsible for compliance with all applicable institutional and regulatory requirements in their jurisdiction.
Preparation Reference Guide
Research Solution Reference Calculator
Pre-filled with 10mg. Enter your solvent volume and target amount to see concentration and units on a U-100 syringe scale.
Concentration—
Volume to draw—
Syringe units (U-100)—
Per insulin unit—
For research-use calculations only. Always verify measurements independently — not medical guidance.
Questions before you order?
Browse the FAQ for documentation, storage, and sourcing answers, or contact our support team directly. We aim to respond to all research procurement inquiries within one business day.
FAQ
Frequently Asked Questions
TB-500 is the common research designation for a synthetic acetate fragment of Thymosin Beta-4, a protein involved in actin regulation and cellular signalling. The two names are often used interchangeably in research literature, though TB-500 specifically refers to a fragment rather than the full-length protein. Supplied here as TB-500 (Thymosin Beta-4 acetate fragment) for laboratory research purposes.
TB-500 appears in preclinical research literature examining tissue repair processes, cellular motility, angiogenesis, and extracellular matrix interactions. Studies have been conducted primarily in in-vitro and animal model contexts within wound biology and vascular research fields. All research outcomes referenced pertain to preclinical models and do not represent clinical findings.
Supplied at ≥99% purity, confirmed through batch-level analytical testing. A Certificate of Analysis is available in the COA tab for independent verification prior to research use. Purity documentation is updated per production batch.
Yes. Batch-specific COA documentation including purity and identity data is accessible in the COA tab on this page. Researchers are encouraged to review this documentation before incorporating the compound into any protocol.
Related
